Wei Gao

7PUBLICATIONS
44CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.

Jatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher

|Oct 14, 2025
Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making.

Linh M Van, Nancy Chen, Kenji Miyazawa

|Aug 21, 2025
Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.

Jatinder Kaur Mukker, Paul Matthias Diderichsen, Farina Hellmann

|Oct 24, 2024
Asia-inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler.

Hong Lu, Lena Klopp-Schulze, Jatinder Kaur Mukker

|Feb 27, 2024
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.

Ping Hu, Haiqing Isaac Dai, James Bourdage

|Nov 16, 2023
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development.

Wei Gao, Jiang Liu, Blerta Shtylla

Pageof 2

Frequent Collaborators

5 joint publications

Karthik Venkatakrishnan

3 joint publications

Rainer Strotmann

2 joint publications

Ioannis Gounaris

2 joint publications

Akash Khandelwal